Vitelliform macular dystrophy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Vitelliform macular dystrophy | |
|---|---|
| Synonyms | Best disease, Best vitelliform macular dystrophy |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Vision loss, blurry vision, metamorphopsia |
| Complications | N/A |
| Onset | Childhood or early adulthood |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutations in the BEST1 gene |
| Risks | Family history of the condition |
| Diagnosis | Ophthalmoscopy, electrooculography, genetic testing |
| Differential diagnosis | Age-related macular degeneration, Stargardt disease |
| Prevention | N/A |
| Treatment | No cure, low vision aids, vitamin A supplementation |
| Medication | N/A |
| Prognosis | Variable, can lead to significant vision loss |
| Frequency | Rare |
| Deaths | N/A |
Vitelliform macular dystrophy (VMD), also known as Best disease, is a rare, genetic eye disorder that affects the retina. It is characterized by the accumulation of yellowish material in the macula, the central part of the retina responsible for sharp, central vision.
Symptoms[edit]
The symptoms of Vitelliform macular dystrophy typically begin in childhood or adolescence, although they can appear later in life. The most common symptom is a gradual decline in central vision, which can affect one or both eyes. Other symptoms may include distorted vision (metamorphopsia), trouble distinguishing between colors (color blindness), and sensitivity to bright light (photophobia).
Causes[edit]
Vitelliform macular dystrophy is caused by mutations in the BEST1 gene. This gene provides instructions for making a protein that is found in the retina. The protein plays a crucial role in the normal functioning of the retina's light-sensing cells. Mutations in the BEST1 gene disrupt the normal functioning of these cells, leading to the symptoms of Vitelliform macular dystrophy.
Diagnosis[edit]
Diagnosis of Vitelliform macular dystrophy is typically made through a comprehensive eye examination, including a detailed examination of the retina. Additional tests may include electroretinography (ERG), optical coherence tomography (OCT), and genetic testing to identify mutations in the BEST1 gene.
Treatment[edit]
There is currently no cure for Vitelliform macular dystrophy. Treatment is focused on managing symptoms and slowing the progression of the disease. This may include the use of low-vision aids, such as magnifying glasses and large-print materials, and referral to services for individuals with visual impairment.
Prognosis[edit]
The prognosis for individuals with Vitelliform macular dystrophy varies. Some individuals may maintain good vision into adulthood, while others may experience a significant decline in vision. Regular follow-up with an ophthalmologist is important to monitor for changes in vision and to manage any complications that may arise.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
